Home › Pancreatic Cancer › Indiana › Fort Wayne
Pancreatic Cancer clinical trials in Fort Wayne, IN
3 studies for Pancreatic Cancer are looking for participants at sites in and around Fort Wayne (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Parkview Research Center, Fort Wayne
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RecruitingPhase 1
- Fort Wayne Medical Oncology and Hematology, Inc /ID# 232593, Fort Wayne
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RecruitingPhase 2
- Ohio State University-Telemedicine, Fort Wayne
About Pancreatic Cancer
The pancreas is a gland behind your stomach that produces insulin. Pancreatic cancer is hard to catch early. Find out about risk factors and symptoms.
More about Pancreatic Cancer on MedlinePlus
Pancreatic Cancer trials in other cities
- Houston, TX61 studies
- New York City, NY60 studies
- Boston, MA43 studies
- Nashville, TN39 studies
- Los Angeles, CA35 studies
- St. Louis, MO33 studies
- Arlington, VA33 studies
- Baltimore, MD31 studies
- San Antonio, TX31 studies
- Philadelphia, PA26 studies
- Tampa, FL26 studies
- Durham, NC24 studies
Other studies in Fort Wayne
- Non-Small Cell Lung Cancer17 studies
- Ovarian Cancer8 studies
- Cancer (all types)7 studies
- Chronic Lymphocytic Leukemia7 studies
- Breast Cancer7 studies
- Lung Cancer6 studies
- Metastatic Cancer6 studies
- Endometrial Cancer5 studies
- Melanoma4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Triple-Negative Breast Cancer4 studies
- Colorectal Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.